Dentsply Sirona, the world’s largest manufacturer of diversified professional dental products and technologies, announces its participation at the Academy of Osseointegration’s (AO) Annual Meeting 2025, taking place from March 27 to 29 in Seattle, WA. Dentsply Sirona will spotlight its latest innovation—the MIS LYNX implant—alongside an engaging Corporate Forum focused on the continuous evolution of implant dentistry.
Attendees are invited to visit Dentsply Sirona at booth #401 to experience firsthand the new MIS LYNX implant, a premium, all-in-one implant system. This versatile and reliable solution is designed for a wide range of clinical applications.
Visitors will have the opportunity to explore interactive demonstrations and discuss with experts how this next-generation implant can achieve results across diverse clinical scenarios, enhancing clinicians’ practices and giving them greater confidence in patient care.
Join the Dentsply Sirona Corporate Forum
“Controversy & Complexity in Implant Dentistry – A 40-Year Journey of Continuous Evolution” will provide an insightful exploration of how key innovations, scientific advancements, and evolving best practices have shaped modern implant dentistry. Moderated by Joe Schmidt, DDS, and Charlotte Almgren, DDS, the forum will highlight real-world clinical cases and cutting-edge digital workflows that simplify complex implant treatments, as well as celebrate the 40-year anniversary of the Astra Tech Implant System.
Attendees will gain valuable insights into the latest regenerative strategies for hard and soft tissue stability, the power of digital ecosystems in full-arch restorations, and the clinical benefits of conical connection systems. The forum will conclude with an interactive panel discussion, where leading experts will tackle unscheduled patient scenarios, providing practical advice on handling complex clinical and medical decisions.
Through dynamic and collaborative sessions, clinicians will better understand how to merge outstanding clinical skills with the latest materials and technologies, promoting long-lasting patient satisfaction and successful implant outcomes.
“Our presence at AO 2025 reflects Dentsply Sirona’s unwavering commitment to advancing implant dentistry through innovative solutions and evidence-based education,” said Rodrigo Canelhas, group vice president, implant and prosthetic solutions at Dentsply Sirona. “With the introduction of the MIS LYNX implant and an engaging corporate forum program, we aim to empower clinicians with the knowledge, tools, and technology needed to achieve the best possible patient outcomes.”
For more information about Dentsply Sirona’s implant solutions, visit Dental Implant Systems: Discover now! | Dentsply Sirona USA.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive range of dental and oral health products, as well as other consumable medical devices, under a strong portfolio of world-class brands.
Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better, safer dental treatments. The company’s headquarters is located in Charlotte, North Carolina. Its shares are listed on Nasdaq under the symbol XRAY.
Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
DISCLAIMER
This information and any attachments contain “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference.
You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast” and similar words and expressions. However, these words are not the exclusive means of identifying such statements.
Additionally, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements. These may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations, as well as the prospects of future business growth. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict.
For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially—including risks related to the market for dental products and services, pricing, sales volume, economic conditions, competitive pressures, reliance on key personnel and suppliers, technological developments, regulatory compliance, and mergers or acquisitions—readers are urged to review Dentsply Sirona’s public filings, including its Annual Reports on Form 10-K and reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the company does not assume any obligation to update any forward-looking statements contained in this document or its attachments to reflect new information or future events.
Registered brands, trade names, and logos are used. Even when they appear without a ™ or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for sharing their experiences and testimonials.
